2020
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
Foss FM, Rubinowitz A, Landry ML, Isufi I, Gowda L, Seropian S, Perreault S, Shenoi SV. Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib. Clinical Lymphoma Myeloma & Leukemia 2020, 20: 720-723. PMID: 32727701, PMCID: PMC7316063, DOI: 10.1016/j.clml.2020.06.014.Peer-Reviewed Original ResearchMeSH KeywordsBetacoronavirusCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansImmunocompromised HostLymphoma, T-CellMaleMiddle AgedNitrilesPandemicsPneumonia, ViralPyrazolesPyrimidinesSARS-CoV-2Severity of Illness IndexTransplantation, HomologousTreatment OutcomeConceptsAllogeneic hematopoietic stem cell transplant patientsHematopoietic stem cell transplant patientsSevere acute respiratory syndrome coronavirus 2SARS coronavirus 2 (SARS-CoV-2) infectionSARS-CoV-2 pneumoniaAcute respiratory syndrome coronavirus 2Stem cell transplant patientsSARS-CoV-2 infectionRespiratory syndrome coronavirus 2Coronavirus 2 infectionCell transplant patientsCoV-2 infectionStem cell transplantationSyndrome coronavirus 2High death rateImmunocompromised stateJAK/STAT inhibitor ruxolitinibTransplant patientsCell transplantationCoronavirus 2Novel therapiesInhibitor ruxolitinibPatientsDeath rateRuxolitinib
2016
Parvovirus B19
Landry ML. Parvovirus B19. Microbiology Spectrum 2016, 4: 10.1128/microbiolspec.dmih2-0008-2015. PMID: 27337440, DOI: 10.1128/microbiolspec.dmih2-0008-2015.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, ViralDNA, ViralHumansImmunocompromised HostParvoviridae InfectionsParvovirus B19, HumanConceptsParvovirus B19 infectionIntravenous immunoglobulinB19 infectionIgG antibodiesImmune systemActive parvovirus B19 infectionPrimary parvovirus B19 infectionPure red cell aplasiaMaintenance intravenous immunoglobulinRed cell transfusionSufficient immune responsePatient's immune systemRed cell aplasiaReal-time polymerase chain reaction methodRed cell precursorsB19 variantsGiant pronormoblastsRecurrent anemiaB19 IgMChronic anemiaPolymerase chain reaction methodSevere anemiaTherapeutic optionsPrimary infectionParvovirus B19
1991
Advantages of multiple cell culture systems for detection of mixed-virus infections
Fong C, Landry M. Advantages of multiple cell culture systems for detection of mixed-virus infections. Journal Of Virological Methods 1991, 33: 283-289. PMID: 1783674, DOI: 10.1016/0166-0934(91)90027-w.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCells, CulturedFluorescent Antibody TechniqueHumansImmunocompromised HostTumor Cells, CulturedVirus CultivationVirus DiseasesVirusesConceptsMRC-5 cellsHSV-1MRC-5CMV-positive casesA549 cellsHSV-1 isolatesCell culturesRhesus monkey kidney cell culturesMonkey kidney cell culturesHuman continuous cell lineImmunosuppressed patientsCytomegalovirus antigenFibroblast cell strainsCentrifugation cultureKidney cell culturesViral agentsSimultaneous infectionContinuous cell linesCulture systemShell vialsMore virusesAdenovirus isolatesEmbryo cell culturesCell culture systemMixed virus infections